CareDx, Inc.

CDNA

Precision medicineBiotech & pharmaceuticalsHealthcare diagnostics

$47.90vs prev close▼-0.72(-1.47%)

$12.3752W Range$49.76

95% from low

+11.47 (+30.88%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

3 sells

Concentrated sells

1M net buy

-$3.1M

≈ -67K shares

Portfolio Weight

0.56%

1M +0.17%p

Holding ETFs

1 ETFs

ARKG

Price Effect (Sell)

Shares decreased, but price appreciation increased portfolio weight.

Shares -16.9% · Market value +30.1% · Weight +0.17%p

Trade Intensity

Concentrated sells

Basis: 3 sells · 0 buys in 1M · weight +0.17%p increase

Trade Log3-day SELL streak

Date	Action	ETF	Shares	Close	Est. total
26.08.19	SELL	ARKG	27,486	$46.51	$1.3M
26.08.18	SELL	ARKG	21,947	$46.18	$1.0M
26.08.17	SELL	ARKG	18,022	$46.38	$835.9K
26.07.22	SELL	ARKG	14,662	$37.78	$553.9K
26.07.21	SELL	ARKG	91,904	$38.54	$3.5M
26.07.20	SELL	ARKG	38,076	$38.37	$1.5M
26.07.09	SELL	ARKG	82,101	$29.11	$2.4M
26.07.08	SELL	ARKG	35,859	$27.55	$987.9K
26.07.07	SELL	ARKG	39,151	$28.31	$1.1M
26.05.18	SELL	ARKG	10,892	$20.59	$224.3K
26.05.15	SELL	ARKG	6,356	$19.97	$126.9K
26.05.14	SELL	ARKG	13,525	$20.49	$277.1K
26.05.13	SELL	ARKG	16,398	$20.61	$338.0K
26.05.12	SELL	ARKG	14,403	$21.40	$308.2K
26.05.11	SELL	ARKG	18,013	$21.55	$388.2K

08.19SELL

27,486

ARKGClose$46.51Est. total$1.3M

08.18SELL

21,947

ARKGClose$46.18Est. total$1.0M

08.17SELL

18,022

ARKGClose$46.38Est. total$835.9K

07.22SELL

14,662

ARKGClose$37.78Est. total$553.9K

07.21SELL

91,904

ARKGClose$38.54Est. total$3.5M

07.20SELL

38,076

ARKGClose$38.37Est. total$1.5M

07.09SELL

82,101

ARKGClose$29.11Est. total$2.4M

07.08SELL

35,859

ARKGClose$27.55Est. total$987.9K

07.07SELL

39,151

ARKGClose$28.31Est. total$1.1M

05.18SELL

10,892

ARKGClose$20.59Est. total$224.3K

05.15SELL

6,356

ARKGClose$19.97Est. total$126.9K

05.14SELL

13,525

ARKGClose$20.49Est. total$277.1K

05.13SELL

16,398

ARKGClose$20.61Est. total$338.0K

05.12SELL

14,403

ARKGClose$21.40Est. total$308.2K

05.11SELL

18,013

ARKGClose$21.55Est. total$388.2K

1 / 4

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

1,527,785

Portfolio Weight

0.56%

in ETF 4.19%

Est. Value

$70M

30D Net

-$12M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Buy

Hold

Analyst Targets

avg.

$52.33

vs Current ▲ +7.7% upside

Current$48.61

Low ~ High$40.00 ~ $64.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

BTIG

Buy

$60.00

+23.43%

—

Maintain

2026-08-06

HC Wainwright & Co.

Neutral

$46.00

-5.37%

—

Maintain

2026-07-31

BTIG

Buy

$45.00

-7.43%

—

Maintain

2026-07-16

BTIG

Buy

$28.00

-42.40%

—

Maintain

2026-04-29

BTIG

Buy

$26.00

-46.51%

—

Maintain

2026-02-26

1 / 4

Avg Target

$52.33

vs Current ▲ +7.7% upside

Buy

7 analysts

Buy 4Hold 3

Low $40.00

Current $48.61

High $64.00

Firm	Position	Target	Upside	Close	Action	Date
BTIG	Buy	$60.00	+23.43%	—	Maintain	26.08.06
HC Wainwright & Co.	Neutral	$46.00	-5.37%	—	Maintain	26.07.31
BTIG	Buy	$45.00	-7.43%	—	Maintain	26.07.16
BTIG	Buy	$28.00	-42.40%	—	Maintain	26.04.29
BTIG	Buy	$26.00	-46.51%	—	Maintain	26.02.26

1 / 4

Price Information

Previous Close$48.61

Open$46.99

Day Range$46.05 - $48.72

52-Week Range$12.37 - $49.76

1-Year Change281.25%

Trading Volume

Volume1,160,457

Avg Volume (3mo)1,060,530

Valuation

Market Cap2.5B

Book Value$8.27

Shares Outstanding51,734,223

Financials

Revenue (TTM)458.1M

Net Income111.0M

EPS$2.08

EBITDA12.4M

Profitability

P/E Ratio23.37

P/B Ratio5.88

Return on Equity (ROE)29.49%

Return on Assets (ROA)-0.25%

Profit Margin24.23%

EV/EBITDA173.76

Beta2.42

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)53.35

Company Overview

CareDx, Inc. is a leading company specializing in diagnostic solutions for transplant patients. Their main products include AlloSure and AlloMap tests for monitoring organ transplant health, alongside HLA typing and patient management software. CareDx aims to improve transplant outcomes through advanced diagnostics and digital health tools.

P/B

5.88

High valuation

ROE

29.5%

High return

Beta

2.42

Extreme volatility

RSI(14)

53.4

Neutral

AI-generated summary. Not investment advice.

CareDx, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks